AI assistant

Sign in to chat with this filing

The assistant answers questions, extracts KPIs, and summarises risk factors directly from the filing text.

Sign up Log in

Karo Pharma AB Share Issue/Capital Change 2016

May 31, 2016

6166_rns_2016-05-31_7193ae19-a804-4951-a87d-81774418e18f.pdf

Share Issue/Capital Change

Open in viewer

Opens in your device viewer

PRESS RELEASE 2016-05-31

Change of the number of shares and votes in Karo Pharma

STOCKHOLM, May 31, 2016 - Karo Pharma AB today announces that the company's total number of shares as per May 31, 2016 amounts to 63,907, 194 shares, corresponding to an equal number of votes. The increase in the number of shares and votes results from the recently completed share issues of 13,981,439 shares. Both issues were announced on February 12, 2016.

For further information, please contact:

Henrik Palm, CFO, telephone +46 70 540 40 14 or e-mail [email protected]

About Karo Pharma

Karo Pharma is a health care company focused on developing and marketing of products to pharmacies, fast-moving consumer goods and the health care directly. Karo Pharma is listed on Nasdaq Stockholm.

Karo Pharma publishes this information in accordance with the Swedish Securities Markets Act and/or the Swedish Instruments Trading Act. The information was submitted for publication on May 31, 2016 at 15:00 CET.

This press release is also available on www.karopharma.se and www.newsroom.cision.com